ASBP
Price
$0.55
Change
-$0.00 (-0.00%)
Updated
Apr 16 closing price
Capitalization
N/A
TVTX
Price
$14.64
Change
+$0.07 (+0.48%)
Updated
Apr 17, 01:13 PM (EDT)
Capitalization
1.29B
14 days until earnings call
Ad is loading...

ASBP vs TVTX

Header iconASBP vs TVTX Comparison
Open Charts ASBP vs TVTXBanner chart's image
Aspire Biopharma Holdings
Price$0.55
Change-$0.00 (-0.00%)
Volume$63.19K
CapitalizationN/A
Travere Therapeutics
Price$14.64
Change+$0.07 (+0.48%)
Volume$2.81K
Capitalization1.29B
ASBP vs TVTX Comparison Chart
Loading...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. TVTX commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a StrongBuy and TVTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (ASBP: $0.55 vs. TVTX: $14.57)
Brand notoriety: ASBP and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 10% vs. TVTX: 60%
Market capitalization -- ASBP: $0 vs. TVTX: $1.29B
ASBP [@Biotechnology] is valued at $0. TVTX’s [@Biotechnology] market capitalization is $1.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TVTX’s TA Score shows that 4 TA indicator(s) are bullish.

  • TVTX’s TA Score: 4 bullish, 5 bearish.

Price Growth

ASBP (@Biotechnology) experienced а +8.14% price change this week, while TVTX (@Biotechnology) price change was +1.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.47%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -25.65%.

Reported Earning Dates

TVTX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX YTD gains are higher at: -16.361 vs. ASBP (-95.204).
ASBPTVTXASBP / TVTX
CapitalizationN/A1.29B-
EBITDAN/A-265.77M-
Gain YTD-95.204-16.361582%
P/E RatioN/AN/A-
RevenueN/A233M-
Total CashN/A371M-
Total DebtN/A402M-
FUNDAMENTALS RATINGS
TVTX: Fundamental Ratings
TVTX
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
38
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
TVTX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
78%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
TVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAGIX30.56N/A
N/A
Gabelli Global Rising Income and Div I
IASAX9.54N/A
N/A
VY® American Century Sm-Mid Cp Val A
DGLRX19.15N/A
N/A
BNY Mellon Global Stock - I
IGFRX21.90N/A
N/A
Invesco EQV International Equity R6
MKDVX18.60N/A
N/A
BlackRock Equity Dividend K

ASBP and

Correlation & Price change

A.I.dvisor tells us that ASBP and BLUE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ASBP and BLUE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
+0.20%
BLUE - ASBP
26%
Poorly correlated
-7.16%
OCEA - ASBP
25%
Poorly correlated
-1.82%
TVTX - ASBP
25%
Poorly correlated
-2.28%
BHVN - ASBP
25%
Poorly correlated
+0.65%
EDIT - ASBP
24%
Poorly correlated
-5.93%
More